EVOKE WEALTH, LLC: TTWO position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EVOKE WEALTH, LLC on TTWO, newest first. How the timeline and the estimate are built.
EVOKE WEALTH, LLC held 0 TTWO shares at 2026-06-30 per its 13F-HR filed 2026-08-10.
the latest 13F is the newest step
- period ended2026-06-3013F 0 sharesChange vs previous 13F -2,002 shares
13F-HR 0001172661-26-003223 filed by EVOKE WEALTH, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2026-03-3113F 2,002 sharesChange vs previous 13F +760 shares
0.01% of the 13F portfolio, value $395,395.
13F-HR 0001172661-26-001997 filed by EVOKE WEALTH, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,242 sharesChange vs previous 13F +20 shares
0.01% of the 13F portfolio, value $317,989.
13F-HR 0001172661-26-000529 filed by EVOKE WEALTH, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,222 sharesChange vs previous 13F -65 shares
0.01% of the 13F portfolio, value $315,716.
13F-HR 0001172661-25-004907 filed by EVOKE WEALTH, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,287 sharesChange vs previous 13F +39 shares
0.01% of the 13F portfolio, value $312,548.
13F-HR 0001172661-25-002928 filed by EVOKE WEALTH, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,248 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $258,648.
13F-HR 0001172661-25-001752 filed by EVOKE WEALTH, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).